Bausch Health Companies
(NYSE:BHC)
$6.785
-0.115[-1.67%]
Last update: 2:19PM (Delayed 15-Minutes)
Get Real Time Here
Day Range6.68 - 6.9952 Wk Range4 - 28.08Open / Close6.78 / -Float / Outstanding317.8M / 361.9M
Vol / Avg.2.3M / 6.8MMkt Cap2.5BP/E9.7250d Avg. Price6.98
Div / Yield-Payout Ratio-Total Float317.8MEPS1.1

Bausch Health Companies Stock (NYSE:BHC), Quotes and News Summary

Bausch Health Companies Stock (NYSE: BHC) stock price, news, charts, stock research, profile.

Loading...
Day Range6.68 - 6.9952 Wk Range4 - 28.08Open / Close6.78 / -Float / Outstanding317.8M / 361.9M
Vol / Avg.2.3M / 6.8MMkt Cap2.5BP/E9.7250d Avg. Price6.98
Div / Yield-Payout Ratio-Total Float317.8MEPS1.1
PRNewswire - Jul 20, 2022, 7:00AM
PRNewswire - Jun 16, 2022, 5:30PM
Seeking Alpha - Nov 2, 2022, 2:17PM
Seeking Alpha - Oct 12, 2022, 5:32PM
Seeking Alpha - Oct 7, 2022, 4:12AM
Seeking Alpha - Sep 7, 2022, 1:05AM
InvestorPlace - Aug 31, 2022, 2:25PM
Seeking Alpha - Aug 31, 2022, 5:05AM
Seeking Alpha - Aug 22, 2022, 5:16PM
Formerly known as Valeant Pharmaceuticals, Bausch Health is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Bausch+Lomb (45% of revenue), Salix Pharmaceuticals (24%), international pharma (14%), ortho dermatology (7%), and diversified products (10%). Bausch is the market leader in consumer visioncare in India and China and the fourth-largest visioncare company by sales in the United States.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-22
REV
Q3 2022Est.ActualSurprise
EPS1.2600.760 -0.5000
REV2.800B2.046B-754.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Bausch Health Companies (BHC) stock?

A

You can purchase shares of Bausch Health Companies (NYSE: BHC) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Bausch Health Companies's (BHC) competitors?

A

There are no as such competitors for Bausch Health Companies.

Q

What is the target price for Bausch Health Companies (BHC) stock?

A

The latest price target for Bausch Health Companies (NYSE: BHC) was reported by Piper Sandler on Friday, September 9, 2022. The analyst firm set a price target for 6.00 expecting BHC to fall to within 12 months (a possible -11.57% downside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Bausch Health Companies (BHC)?

A

The stock price for Bausch Health Companies (NYSE: BHC) is $6.785 last updated Today at November 28, 2022, 7:19 PM UTC.

Q

Does Bausch Health Companies (BHC) pay a dividend?

A

There are no upcoming dividends for Bausch Health Companies.

Q

When is Bausch Health Companies (NYSE:BHC) reporting earnings?

A

Bausch Health Companies’s Q4 earnings are confirmed for Wednesday, February 22, 2023.

Q

Is Bausch Health Companies (BHC) going to split?

A

There is no upcoming split for Bausch Health Companies.

Q

What sector and industry does Bausch Health Companies (BHC) operate in?

A

Bausch Health Companies is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NYSE.